Novel BioEnergy IVS: Financial statements 2020
CVR: 40446338
Source: annual report 2020, Danish Business Authority
01/04/2019 – 31/03/2020
Novel BioEnergy IVS (CVR 40446338) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 5,000 and a net result of DKK 2,646. The profit margin was 52.9%. Equity in the 2020 report amounted to DKK 2,646. The solvency ratio was 100%.
- Revenue
- DKK 5,000
- Gross Profit
- DKK 2,646
- Profit/Loss
- DKK 2,646
- Equity
- DKK 2,646
- Total Assets
- DKK 2,646
Official annual report
How creditworthy is Novel BioEnergy IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Novel BioEnergy IVS
Novel BioEnergy IVS was a Danish company of the type Iværksætterselskab based in Frederiksværk, founded in 2019. The company has been dissolved on 6 December 2021. The company was registered under the industry Ikke-finansielle holdingselskaber. In 2020, the company reported revenue of DKK 5,000 and a net result of DKK 2,646. Equity in the 2020 report amounted to DKK 2,646.
